Navigation Links
BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label

FLORHAM PARK, N.J., Dec. 17 /PRNewswire/ -- BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.

"Aseptrol S10 - Tab delivers a broad spectrum disinfectant as stated in the EPA label and kills a large number of pathogens, such as H1N1 virus, Avian Influenza A (H3N2), Influenza A, and HIV, on contact surfaces," said Gary Dee, Business Director, Home and Personal Care, Care Chemicals North America at BASF. "The tablet is stable when dry and is packed in foil pouches, saving energy and reducing overall logistics costs."

High efficiency CIO2 is formed in the pores of the tablet when immersed in water. As the tablet dissolves, this powerful oxidizer disperses into the bulk solution. Using the Aseptrol S10 - Tab is as easy as Drop, Spray and Wipe: Drop the tablet in a spray bottle containing water, spray it evenly on a non-porous surface and wipe the surface until dry. Treated surfaces must remain wet for 10 minutes (or 30 minutes for Foot and Mouth Disease Virus). The solution does not leave a residue.

Care Chemicals and Formulators

BASF's Care Chemicals division develops, produces and markets a comprehensive range of products for nutrition, pharmaceuticals, cosmetics, detergents & cleaners, and industrial & chemical applications. As a result of focused research and development, we are a preferred partner of our customers worldwide.

The products offered by BASF Care Chemicals include vitamins, carotenoids, organic acids, active pharmaceutical ingredients and excipients, aroma chemicals and cosmetic ingredients, chelating agents, surfactants, biocides, waxes and wax emulsions as well as metal surface treatment products.

BASF - The Chemical Company. We don't make a lot of the products you buy. We make a lot of the products you buy better.®

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 15,000 employees in North America, and had sales of approximately $17.5 billion in 2008. For more information about BASF's North American operations, or to sign up to receive news releases by e-mail, visit

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics and performance products to agricultural products, fine chemicals and oil and gas. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than euro 62 billion in 2008 and had approximately 97,000 employees as of the end of the year. Further information on BASF is available on the Internet at

Aseptrol S10 - Tab is a registered trademark of BASF Corporation.

SOURCE BASF Corporation

SOURCE BASF Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix Receives URAC Health Utilization Management Accreditation
2. Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
3. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
4. Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
5. EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution
6. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
7. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
8. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
9. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
10. Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg
11. Dynatronics Receives 180-Day NASDAQ Extension
Post Your Comments:
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):